Truist Financial Corp Teva Pharmaceutical Industries LTD Transaction History

Truist Financial Corp

  • $62.9 Billion
  • Q3 2024

A detailed history of Truist Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Truist Financial Corp holds 1,388,822 shares of TEVA stock, worth $30.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,388,822
Previous 3,885,251 64.25%
Holding current value
$30.7 Million
Previous $63.1 Million 60.36%
% of portfolio
0.04%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$15.81 - $18.96 $39.5 Million - $47.3 Million
-2,496,429 Reduced 64.25%
1,388,822 $25 Million
Q2 2024

Aug 20, 2024
BUY
$12.78 - $17.4 $3.25 Million - $4.43 Million
254,483 Added 7.01%
3,885,251 $63.1 Million
Q1 2024

May 10, 2024
BUY
$10.67 - $14.43 $37.3 Million - $50.5 Million
3,496,746 Added 2609.08%
3,630,768 $51.2 Million
Q4 2023

Feb 02, 2024
BUY
$8.12 - $10.63 $14,339 - $18,772
1,766 Added 1.34%
134,022 $1.4 Million
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $313,374 - $448,276
-41,895 Reduced 24.06%
132,256 $1.35 Million
Q2 2023

Aug 01, 2023
BUY
$7.2 - $9.47 $264,326 - $347,662
36,712 Added 26.71%
174,151 $1.31 Million
Q1 2023

May 05, 2023
SELL
$8.36 - $11.37 $114,506 - $155,734
-13,697 Reduced 9.06%
137,439 $1.22 Million
Q4 2022

Feb 17, 2023
SELL
$7.95 - $9.48 $65,388 - $77,973
-8,225 Reduced 5.16%
151,136 $1.38 Million
Q3 2022

Oct 26, 2022
BUY
$6.86 - $11.95 $174,737 - $304,390
25,472 Added 19.02%
159,361 $1.29 Million
Q2 2022

Jul 22, 2022
SELL
$7.38 - $10.4 $222,521 - $313,580
-30,152 Reduced 18.38%
133,889 $1.01 Million
Q1 2022

Apr 22, 2022
SELL
$7.33 - $9.39 $49,997 - $64,049
-6,821 Reduced 3.99%
164,041 $1.54 Million
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $276,539 - $356,700
35,005 Added 25.77%
170,862 $1.37 Million
Q3 2021

Nov 05, 2021
BUY
$8.38 - $10.18 $197,483 - $239,901
23,566 Added 20.99%
135,857 $1.32 Million
Q2 2021

Aug 16, 2021
SELL
$9.9 - $11.56 $22,007 - $25,697
-2,223 Reduced 1.94%
112,291 $1.11 Million
Q1 2021

May 17, 2021
BUY
$10.34 - $12.81 $752,421 - $932,158
72,768 Added 174.31%
114,514 $1.32 Million
Q4 2020

Feb 18, 2021
SELL
$8.61 - $11.04 $591,205 - $758,061
-68,665 Reduced 62.19%
41,746 $402,000
Q3 2020

Nov 13, 2020
BUY
$8.57 - $12.69 $9,598 - $14,212
1,120 Added 1.02%
110,411 $995,000
Q2 2020

Aug 14, 2020
SELL
$8.12 - $13.12 $117,066 - $189,151
-14,417 Reduced 11.65%
109,291 $1.35 Million
Q1 2020

May 15, 2020
SELL
$6.69 - $13.45 $32,867 - $66,079
-4,913 Reduced 3.82%
123,708 $1.11 Million
Q4 2019

Feb 14, 2020
BUY
$6.53 - $10.72 $839,895 - $1.38 Million
128,621 New
128,621 $1.26 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email